Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 2
1961 1
1963 1
1974 1
1979 11
1980 44
1981 51
1982 53
1983 46
1984 62
1985 42
1986 43
1987 46
1988 70
1989 89
1990 110
1991 111
1992 127
1993 118
1994 124
1995 125
1996 124
1997 118
1998 105
1999 114
2000 110
2001 105
2002 128
2003 134
2004 94
2005 120
2006 106
2007 113
2008 104
2009 97
2010 139
2011 137
2012 157
2013 138
2014 146
2015 151
2016 158
2017 122
2018 146
2019 72
2020 7
Text availability
Article attribute
Article type
Publication date

Search Results

4,011 results
Results by year
Filters applied: . Clear all
Page 1
Ursodeoxycholic acid and lithocholic acid exert anti-inflammatory actions in the colon.
Ward JBJ, Lajczak NK, Kelly OB, O'Dwyer AM, Giddam AK, Ní Gabhann J, Franco P, Tambuwala MM, Jefferies CA, Keely S, Roda A, Keely SJ. Ward JBJ, et al. Am J Physiol Gastrointest Liver Physiol. 2017 Jun 1;312(6):G550-G558. doi: 10.1152/ajpgi.00256.2016. Epub 2017 Mar 30. Am J Physiol Gastrointest Liver Physiol. 2017. PMID: 28360029 Free article.
Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial.
Chappell LC, Bell JL, Smith A, Linsell L, Juszczak E, Dixon PH, Chambers J, Hunter R, Dorling J, Williamson C, Thornton JG; PITCHES study group. Chappell LC, et al. Lancet. 2019 Sep 7;394(10201):849-860. doi: 10.1016/S0140-6736(19)31270-X. Epub 2019 Aug 1. Lancet. 2019. PMID: 31378395 Free PMC article. Clinical Trial.
Ursodeoxycholic acid for cystic fibrosis-related liver disease.
Cheng K, Ashby D, Smyth RL. Cheng K, et al. Cochrane Database Syst Rev. 2017 Sep 11;9(9):CD000222. doi: 10.1002/14651858.CD000222.pub4. Cochrane Database Syst Rev. 2017. PMID: 28891588 Free PMC article. Review.
Increased prescribing of ursodeoxycholic acid in Norway.
Kolberg ES, Tranung M, Aasarød KM. Kolberg ES, et al. Int J Clin Pharm. 2018 Dec;40(6):1454-1457. doi: 10.1007/s11096-018-0729-2. Epub 2018 Sep 28. Int J Clin Pharm. 2018. PMID: 30267256
A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis.
Corpechot C, Chazouillères O, Rousseau A, Le Gruyer A, Habersetzer F, Mathurin P, Goria O, Potier P, Minello A, Silvain C, Abergel A, Debette-Gratien M, Larrey D, Roux O, Bronowicki JP, Boursier J, de Ledinghen V, Heurgue-Berlot A, Nguyen-Khac E, Zoulim F, Ollivier-Hourmand I, Zarski JP, Nkontchou G, Lemoinne S, Humbert L, Rainteau D, Lefèvre G, de Chaisemartin L, Chollet-Martin S, Gaouar F, Admane FH, Simon T, Poupon R. Corpechot C, et al. N Engl J Med. 2018 Jun 7;378(23):2171-2181. doi: 10.1056/NEJMoa1714519. N Engl J Med. 2018. PMID: 29874528 Free article. Clinical Trial.
4,011 results
Jump to page
Feedback